Información del artículo
El Texto completo está disponible en PDF
References
[1.]
J. Campos, M. Pérez-Vázquez, J. Oteo.
Las estrategias internacionales y las campañas para promover el uso prudente de los antibióticos en los profesionales y los usuarios.
Enferm Infecc Microbiol Clin, 28 (2010), pp. 50-54
[2.]
Council of the European Union. Council Recommendation of 15 November 2001 on the prudent use of antimicrobial agents in human medicine (2002/77/EC). Official Journal of the European Communities 2002; L34/13:5.2.2002. Available from: http://eur-lex.europa.eu/LexUriServ/LexUriServ.do?uri=OJ:L:2002:034:0013:0016:EN:PDF
[3.]
European Commission. Second report from the Commission to the Council on the basis of Member States’ reports on the implementation of the Council Recommendation (2002/77/EC) on the prudent use of antimicrobial agents in human medicine. Available from: http://ec.europa.eu/health/antimicrobial_resistance/key_documents/index_en.htm
[4.]
European Antimicrobial Resistance Surveillance System. EARSS Annual Report 2008. Bilthoven, The Netherlands: National Institute of Public Health and the Environment, 2009. ISBN: 978-90-6960-236-3. Available from: http://www.rivm.nl/earss/Images/EARSS%202008_final_tcm61-65020.pdf
[5.]
L. Martínez-Martínez, J. Calvo.
Desarrollo de las resistencias a los antibióticos: causas, consecuencias y su importancia para la salud pública.
Enferm Infecc Microbiol Clin, 28 (2010), pp. 4-9
[6.]
ECDC/EMEA Joint Technical Report. The bacterial challenge: time to react. Stockholm, European Centre for Disease Prevention and Control & London, European Medicines Agency, 2009. Available from: http://ecdc.europa.eu/en/publications/Publications/0909_TER_The_Bacterial_Challenge_Time_to_React.pdf
[7.]
European Commission. Eurostat. http://epp.eurostat.ec.europa.eu.
[8.]
H. Goossens, M. Ferech, R. Vander Stichele, M. Elseviers, For the ESAC Project Group.
Outpatient antibiotic use in Europe and association with resistance: a cross-national database study.
Lancet, 365 (2005), pp. 579-587
[9.]
N. Van de Sande-Bruinsma, H. Grundmann, D. Verloo, E. Tiemersma, J. Monen, H. Goossens, et al.
Antimicrobial drug use and resistance in Europe.
Emerg Infect Dis, 14 (2008), pp. 1722-1730
[10.]
J. Campos, M. Ferech, E. Lázaro, F. De Abajo, J. Oteo, P. Stephens, et al.
Surveillance of outpatient antibiotic consumption in Spain according to sales data and reimbursement data.
J Antimicrob Chemother, 60 (2007), pp. 698-701
[11.]
J.M. López-Lozano, D.L. Monnet, A. Yagüe, A. Burgos, N. Gonzalo, P. Campillos, et al.
Modelling and forecasting antimicrobial resistance and its dynamic relationship to antimicrobial use: a time series analysis.
Int J Antimicrob Agents, 14 (2000), pp. 21-31
[12.]
D.L. Monnet, J.M. López-Lozano, P. Campillos, A. Burgos, A. Yagüe, N. Gonzalo.
Making sense of antimicrobial use and resistance surveillance data: application of ARIMA and transfer function models.
Clin Microbiol Infect, 7 (2001), pp. 29-36
[13.]
P.M. Lepper, E. Grusa, H. Reichl, J. Högel, M. Trautmann.
Consumption of imipenem correlates with beta-lactam resistance in Pseudomonas aeruginosa.
Antimicrob Agents Chemother, 46 (2002), pp. 2920-2925
[14.]
E. Lazáro-Bengoa, F.J. De Abago Iglesias, A. López-Navas, M.J. Fernández-Cortizo.
Uso de antibióticos en España y marco regulador para su desarrollo clínico en la Unión Europea.
Enferm Infecc Microbiol Clin, 28 (2010), pp. 10-16
[15.]
European Surveillance of Antimicrobial Consumption (ESAC). ESAC Yearbook 2008. Antwerp, Belgium: University of Antwerp, 2010. ISBN number: 9789057282911. Available from: http://www.esac.ua.ac.be/download.aspx?c=*ESAC2&n=50036&ct=50033&e=50420
[16.]
C. Llor, J.M. Cots.
The sale of antibiotics without prescription in pharmacies in Catalonia, Spain.
Clin Infect Dis, 48 (2009), pp. 1345-1349
[17.]
L. Salar Ibáñez, M. Eyaralar Riera, V. Baixauli fernández, B. Fitéw Novellas, F. García Cebrían, J. Gernás Camacho.
Demanda de antibíoticos sin receta en farmacia comunitaria.
Pharmaceutical Care España, 8 (2006), pp. 173-178
[18.]
Special Eurobarometer 338. Antimicrobial resistance, November-December 2009. Available from: http://ec.europa.eu/health/antimicrobial_resistance/eurobarometers/index_en.htm
[19.]
F. Ansari, M. Erntell, H. Goossens, P. Davey.
The European surveillance of antimicrobial consumption (ESAC) point-prevalence survey of antibacterial use in 20 European hospitals in 2006.
Clin Infect Dis, 49 (2009), pp. 1496-1504
[20.]
L. Domínguez Rodríguez, M.A. Moreno Romo, M.C. Porrero Calonge, S. Téllez Peña.
Uso prudente de antimicrobianos y propuestas de mejora en veterinaria.
Enferm Infecc Microbiol Clin, 28 (2010), pp. 40-44
[21.]
Joint opinion on antimicrobial resistance (AMR) focused on zoonotic infections. Scientific Opinion of the European Centre for Disease Prevention and Control; Scientific Opinion of the Panel on Biological Hazards; Opinion of the Committee for Medicinal Products for Veterinary Use; Scientific Opinion of the Scientific Committee on Emerging and Newly Identified Health Risks. Stockholm, European Centre for Disease Prevention and Control; Parma, European Food Safety Agency; London, European Medicines Agency & Brussels, Scientific Committee on Emerging and Newly Identified Health Risks: 2009. Available from: http://www.efsa.europa.eu/en/scdocs/doc/1372.pdf
[22.]
M.E. Falagas, I.A. Bliziotis.
Pandrug-resistant Gram-negative bacteria: the dawn of the post-antibiotic era?.
Int J Antimicrob Agents, 29 (2007), pp. 630-636
[23.]
Lepape A, Monnet DL, on behalf of participating members of the European Society of Intensive Care Medicine. Experience of European intensive care physicians with infections due to antibiotic-resistant bacteria, 2009. Euro Surveill. 2009;14. pii: 19393.
[24.]
M. Souli, I. Galani, H. Giamarellou.
Emergence of extensively drug-resistant and pandrug-resistant Gram-negative bacilli in Europe.
Euro Surveill, (2008), pp. 13
[25.]
C. García-Rey.
El papel de la industria farmacéutica. ¿Por qué no se comercializan nuevos antibióticos?.
Enferm Infecc Microbiol Clin, 28 (2010), pp. 45-49
[26.]
Council of the European Union. Council Recommendation of 9 June 2009 on patient safety, including the prevention and control of healthcare associated infections (2009/C 151/01). Official Journal of the European Union, 3.7.2009. Available from: http://eur-lex.europa.eu/LexUriServ/LexUriServ.do?uri=OJ:C:2009:151:0001:0006:EN:PDF
[27.]
Anonymous.
Recent trends in antimicrobial resistance among Streptococcus pneumoniae and Staphylococcus aureus isolates: the French experience.
Euro Surveill, (2008), pp. 13
[28.]
H. Goossens, S. Coenen, M. Costers, S. De Corte, A. De Sutter, B. Gordts, et al.
Achievements of the Belgian Antibiotic Policy Coordination Committee (BAPCOC).
Euro Surveill, (2008), pp. 13
[29.]
S. Earnshaw, D.L. Monnet, B. Duncan, J. O’Toole, K. Ekdahl, H. Goossens, et al.
European Antibiotic Awareness Day, 2008 - the first Europe-wide public information campaign on prudent antibiotic use: methods and survey of activities in participating countries.
Euro Surveill, (2009), pp. 14
[30.]
C. Llor.
Uso prudente de antibióticos y propuestas de mejora desde la atención primaria.
Enferm Infecc Microbiol Clin, 28 (2010), pp. 17-22
[31.]
A. Hernández-Merino.
Uso prudente de antibióticos: propuestas de mejora desde la pediatría comunitaria.
Enferm Infecc Microbiol Clin, 28 (2010), pp. 23-27
[32.]
J.M. Cisneros, C. Ortiz-Leyba, J.A. Lepe, I. Obando, M. Conde, A. Cayuela, et al.
Uso prudente de antibióticos y propuestas de mejora desde la medicina hospitalaria.
Enferm Infecc Microbiol Clin, 28 (2010), pp. 28-31
[33.]
F. Gudiol Munté.
Uso prudente de antibióticos y propuestas de mejora en los centros sociosanitarios.
Enferm Infecc Microbiol Clin, 28 (2010), pp. 32-35
[34.]
O. Delgado Sánchez, J. Bautista Palomo, M. Sora Ortega, F. Moranta Ribas.
Uso prudente de antibióticos y propuestas de mejora desde la farmacia comunitaria y hospitalaria.
Enferm Infecc Microbiol Clin, 28 (2010), pp. 36-39
Copyright © 2010. Elsevier España S.L.. All rights reserved
